Reuter C - Search Results

1

A randomised phase 2 study combining LY2181308 sodium (survivin antisense oligonucleotide) with first-line docetaxel/prednisone in patients with castration-resistant prostate cancer.

Wiechno P, Somer BG, Mellado B, Chłosta PL, Cervera Grau JM, Castellano D, Reuter C, Stöckle M, Kamradt J, Pikiel J, Durán I, Wedel S, Callies S, André V, Hurt K, Brown J, Lahn M, Heinrich B. Wiechno P, et al. Among authors: reuter c. Eur Urol. 2014 Mar;65(3):516-20. doi: 10.1016/j.eururo.2013.10.039. Epub 2013 Nov 6. Eur Urol. 2014. PMID: 24246407 Clinical Trial.

2

Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer.

Reuter CW, Morgan MA, Ivanyi P, Fenner M, Ganser A, Grünwald V. Reuter CW, et al. World J Urol. 2010 Jun;28(3):391-8. doi: 10.1007/s00345-010-0527-5. Epub 2010 Mar 14. World J Urol. 2010. PMID: 20229232

3

Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial.

Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Hölscher T, Gut P, Polat B, Hildebrandt G, Müller AC, Plasswilm L, Papachristofilou A, Schär C, Sumila M, Zaugg K, Guckenberger M, Ost P, Reuter C, Bosetti DG, Khanfir K, Gomez S, Wust P, Thalmann GN, Aebersold DM; Swiss Group for Clinical Cancer Research (SAKK). Ghadjar P, et al. Among authors: reuter c. Eur Urol. 2021 Sep;80(3):306-315. doi: 10.1016/j.eururo.2021.05.033. Epub 2021 Jun 14. Eur Urol. 2021. PMID: 34140144 Clinical Trial.

4

Prognostic role of docetaxel-induced suppression of free testosterone serum levels in metastatic prostate cancer patients.

Kappler P, Morgan MA, Ivanyi P, Brunotte SJ, Ganser A, Reuter CWM. Kappler P, et al. Sci Rep. 2021 Aug 12;11(1):16457. doi: 10.1038/s41598-021-95874-y. Sci Rep. 2021. PMID: 34385568 Free PMC article.

5

Does the onset of bone metastasis in sunitinib-treated renal cell carcinoma patients impact the overall survival?

Ivanyi P, Koenig J, Trummer A, Busch JF, Seidel C, Reuter CW, Ganser A, Grünwald V. Ivanyi P, et al. Among authors: reuter cw. World J Urol. 2016 Jul;34(7):909-15. doi: 10.1007/s00345-015-1707-0. Epub 2015 Nov 19. World J Urol. 2016. PMID: 26586475

6

Improving survival in metastatic renal cell carcinoma (mRCC) patients: do elderly patients benefit from expanded targeted therapeutic options?

Eggers H, Schünemann C, Grünwald V, Rudolph L, Tiemann ML, Reuter C, Anders-Meyn MF, Ganser A, Ivanyi P. Eggers H, et al. Among authors: reuter c. World J Urol. 2022 Oct;40(10):2489-2497. doi: 10.1007/s00345-022-04110-3. Epub 2022 Aug 2. World J Urol. 2022. PMID: 35916904 Free PMC article.

7

Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patients.

Seidel C, Fenner M, Merseburger AS, Reuter C, Ivanyi P, Länger F, Ganser A, Grünwald V. Seidel C, et al. Among authors: reuter c. World J Urol. 2011 Jun;29(3):355-60. doi: 10.1007/s00345-010-0642-3. Epub 2011 Jan 22. World J Urol. 2011. PMID: 21258806

8

Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy.

von Klot CA, Kuczyk MA, Boeker A, Reuter C, Imkamp F, Herrmann TR, Tezval H, Kramer MW, Perner S, Merseburger AS. von Klot CA, et al. Among authors: reuter c. Oncol Lett. 2017 Jan;13(1):22-28. doi: 10.3892/ol.2016.5392. Epub 2016 Nov 17. Oncol Lett. 2017. PMID: 28123517 Free PMC article.

9

Treatment with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma is associated with drug-induced hyperparathyroidism: a single center experience in 59 patients.

Ivanyi P, Winkler T, Grosshennig A, Reuter C, Merseburger AS, Ganser A, Grünwald V. Ivanyi P, et al. Among authors: reuter c. World J Urol. 2010 Jun;28(3):311-7. doi: 10.1007/s00345-010-0558-y. Epub 2010 May 5. World J Urol. 2010. PMID: 20443009

10

Retrospective analyses of patient characteristics having predictive impact on survival under everolimus.

Seidel C, Fenner M, Reuter C, Merseburger AS, Ganser A, Grünwald V. Seidel C, et al. Among authors: reuter c. Onkologie. 2011;34(3):111-4. doi: 10.1159/000324668. Epub 2011 Feb 15. Onkologie. 2011. PMID: 21358215

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

475 results

Search Page

Filters